SCHEMBL4882314

SCHEMBL4882314

C=CC(F)NC(=O)c1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTRB1 P17538 5/20 0.49
LMNA P02545 3/20 0.46
HPGD P15428 3/20 0.46
SLC1A2 P43004 1/20 0.46
HDAC3 O15379 1/20 0.45
CA12 O43570 1/20 0.45
CA1 P00915 1/20 0.45
IDO1 P14902 1/20 0.45
ALOX15 P16050 1/20 0.45
HDAC1 Q13547 1/20 0.45
CA9 Q16790 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HSD17B10 Q99714 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
ALDH1A1 P00352 3/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28227259 0.79 LMNA (0.47) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL5134568 0.78 CTRB1 (0.56) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL11292044 0.78 ALDH1A1 (0.50) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL4442412 0.78 SLC1A2 (0.54) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL2053215 0.77 KDM4E (0.51) LMNAHPGDCA1CA9HSD17B10
SCHEMBL9509041 0.76 CYP1A2 (0.55) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL10779754 0.75 LMNA (0.44) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL782748 0.75 HPGD (0.45) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL28983041 0.75 CTRB1 (0.53) CTRB1LMNAHPGDSLC1A2HDAC3
SCHEMBL27693084 0.75 SLC1A2 (0.55) CTRB1LMNAHPGDSLC1A2HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2243769-B1 PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE FLUOROAMINE CENTRAL GLASS CO LTD (JP) 2017-06-28 EP disclosed
US-7405331-B2 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2008-07-29 US disclosed
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2006-07-27 US disclosed
EP-1500641-A1 HIGH-PURITY (FLUOROALKYL)BENZENE DERIVATIVE AND PROCESS FOR PRODUCING THE SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2005-01-26 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060167324-A1 High-purity (fluoroalkyl)benzene derivative and process for producing the same HBB, AFF4, AFF2 CTRB1 904/4885LMNA 2219/4885HPGD 777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.